Research and regulatory reference
Tesofensine
A source-linked reference on the identity and evidence context of Tesofensine. Sources checked 6 September 2026.
Source and review status
Published sources checked
Sources checked on: 6 September 2026
Qualified clinical review: Pending. This page has not been clinically reviewed.
About this source check
AI-assisted editorial source checking covers the cited material and its stated limits. It is not a systematic review, verification of a supplied product, or clinical sign-off.
Editorial role: InfoAddict. Last material change: 6 September 2026. Next source review: 6 December 2026.
Identity
Tesofensine is a triple monoamine-reuptake inhibitor, not a peptide.
Sources: PubMed, National Library of Medicine
A named substance and a finished product are different claims. The name does not verify formulation, concentration, purity or equivalence to material used in a study.
Research context
The trial reported both weight outcomes and adverse events over 24 weeks, and said phase-III confirmation was needed. This is not a personal treatment recommendation.
Sources: PubMed, National Library of Medicine
The source documents a specific identity or research setting. It does not independently verify a commercial product, establish product equivalence or answer a person-specific health question.
Evidence boundary
This entry reports the limited source context above. It does not make a personal treatment recommendation or infer a result from a different molecule, formulation, model or study population.
The appropriate conclusion is limited to the cited record, not to untested products or uses.
Published sources
- Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial
PubMed, National Library of Medicine. Published 2008; accessed 6 September 2026.
Supports: A phase-II randomised trial in 203 adults with obesity.
Change history
| Date | Change | Clinical-review status |
|---|---|---|
| 6 September 2026 | Source-linked reference published | Pending |
Keep a private record
UpgradeYourself lets you keep private records of routines and observations you choose to discuss with a qualified health professional. This reference does not recommend starting, stopping or changing an item.